Baird Financial Group’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
Other funds holding ABMD
TRSOTSOK
BTI
IA
AW
HNB
Baird Financial Group's ABMD Position: Q4 2022 in Review
Baird Financial Group sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 109,682 shares — an estimated $26.9M sold.
Baird Financial Group first reported a position in ABMD in Q3 2016 and held it in 22 quarters. The position peaked at $53.7M in Q2 2019. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.
- Baird Financial Group reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
- Baird Financial Group sold 109,682 Abiomed Inc shares in Q4 2022, an estimated $26.9M.
- Baird Financial Group first reported a position in Abiomed Inc in Q3 2016 and held it in 22 quarters.
- Baird Financial Group's Abiomed Inc position peaked at $53.7M in Q2 2019.
- 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.
Based on Baird Financial Group's 13F filing for Q4 2022, filed 13 Feb 2023.